相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
D. Hristodorov et al.
BRITISH JOURNAL OF CANCER (2013)
A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene
Hui Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Brentuximab Vedotin: A CD30-Directed Antibody-Cytotoxic Drug Conjugate
Ashley M. Newland et al.
PHARMACOTHERAPY (2013)
Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model
S. Schiffer et al.
BLOOD CANCER JOURNAL (2013)
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model
Alessa Pardo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen et al.
NATURE BIOTECHNOLOGY (2012)
A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
John E. Weldon et al.
FEBS JOURNAL (2011)
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
Laurent Ducry et al.
BIOCONJUGATE CHEMISTRY (2010)
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Andreas Josting et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
Mrudula Mathew et al.
CANCER SCIENCE (2009)
Potent antibody drug conjugates for cancer therapy
Peter D. Senter
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Targeted Restoration of Down-regulated DAPK2 Tumor Suppressor Activity Induces Apoptosis in Hodgkin Lymphoma Cells
Mehmet Kemal Tur et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial
Bojana Pajk et al.
BREAST (2008)
Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells
Christian Hetzel et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
Bettina Stahnke et al.
MOLECULAR CANCER THERAPEUTICS (2008)
How do microtubule-targeted drugs work? An overview
Mary Ann Jordan et al.
CURRENT CANCER DRUG TARGETS (2007)
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Immunotoxins for targeted cancer therapy
Robert J. Kreitman
AAPS JOURNAL (2006)
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
A Sureda et al.
ANNALS OF ONCOLOGY (2005)
Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions
S Barth et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
分享论文
